Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.76M 1.54M 1.45M 1.32M 2.47M 169M 2.48M 17.34M 6.7M 86.07M 6.63M 6.48M 277M | P/E 2021 |
-1.77x | P/E 2022 | -0.89x |
|---|---|---|---|---|---|
| Enterprise Value | -20.07M -17.49M -16.51M -14.99M -28.09M -1.92B -28.19M -197M -76.22M -979M -75.4M -73.72M -3.15B | EV / Sales 2021 |
-5.43x | EV / Sales 2022 | -10.4x |
| Free-Float |
98.45% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 2024-02-22 |
Richard Fair
CEO | Chief Executive Officer | 57 | 2017-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.68% | -18.17% | - | - | 822K | ||
| -0.31% | +5.79% | +47.13% | +99.00% | 70.88B | ||
| +0.39% | +2.06% | +39.38% | +78.71% | 62.49B | ||
| +0.50% | +7.13% | +33.27% | +20.02% | 26.34B | ||
| -3.21% | -7.27% | -17.10% | +370.22% | 26.21B | ||
| -2.64% | -0.69% | -0.17% | -11.56% | 24.13B | ||
| +0.71% | +8.03% | +25.03% | -13.74% | 20.72B | ||
| +2.12% | -5.86% | +161.58% | +329.34% | 15.36B | ||
| -0.22% | +3.99% | +45.54% | +171.32% | 14.46B | ||
| +0.73% | +1.71% | -5.51% | +859.68% | 14.24B | ||
| Average | -0.86% | +1.74% | +36.57% | +211.44% | 30.54B | |
| Weighted average by Cap. | -0.28% | +1.49% | +35.68% | +150.57% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.4M 5.1M 4.63M 8.68M 594M 8.71M 60.92M 23.54M 302M 23.29M 22.77M 974M | 1.5M 1.31M 1.23M 1.12M 2.1M 144M 2.11M 14.74M 5.7M 73.16M 5.63M 5.51M 236M |
| Net income | -9.7M -8.45M -7.98M -7.25M -13.58M -930M -13.63M -95.36M -36.85M -473M -36.45M -35.64M -1.52B | -24.97M -21.76M -20.54M -18.65M -34.95M -2.39B -35.07M -245M -94.83M -1.22B -93.8M -91.72M -3.92B |
| Net Debt | -46.16M -40.21M -37.96M -34.47M -64.59M -4.42B -64.81M -454M -175M -2.25B -173M -170M -7.25B | -21.84M -19.02M -17.96M -16.31M -30.56M -2.09B -30.66M -215M -82.93M -1.07B -82.02M -80.2M -3.43B |
Employees
13
















